Delivery Order SPE2DB22D2006-SPE2DB24FV5XM

Award Date 10/30/23
Potential Completion Date 10/31/23
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,187.84 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract has a firm fixed price and an ultimate completion date of February 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.32 firm-fixed-price delivery order is for the supply of NALTREXONE 50 MG TABLET 30S, a medication used in the treatment of opioid and alcohol dependence. The contract has a completion date of July 31, 2023 and was awarded on July 28, 2023. This delivery order is part of a larger $999,999,999 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALTREXONE 50 MG TABLET 100S, with a ceiling value of $3,911.20 and a period of performance through June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,299.82, is for the delivery of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,948.05 and is for the delivery of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid and alcohol dependence. The contract is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract does not have...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,766.54 firm fixed-price delivery order is for the supply of NALTREXONE 50 MG TABLET 60S, a medication used in the treatment of opioid addiction. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,809.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALTREXONE 50 MG TABLET 60S, with an ultimate completion date of November 8, 2024. The contract is a delivery order with a firm fixed-price pricing type. This award is not associated with a set-aside designation, indicating open competition. In addition to this...
This federal contract award, valued at $1,136.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of March 20, 2025. The contract is for the supply of NALTREXONE 50 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALTREXONE 50 MG TABLET 60S, with a ceiling value of $13,284.14 and a completion date of May 23, 2025. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $4,945.60 order is for the supply of NALTREXONE 50 MG TABLET 90S, a pharmaceutical product, with a completion date of February 21, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV5XM
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,721.53, is for the supply of NALTREXONE 50 MG TABLET 90S, a medication used in the treatment of opioid use disorder. The contract is a firm fixed-price delivery order with an ultimate completion date of October 31, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 9:49 AM